Accuracy of determination of doubling time in lung cancer

Autor Mattson, K., Salmo, M., Holsti, L. R.
Vydáno 1980

Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma.

Autor Björkqvist, A. M., Tammilehto, L., Anttila, S., Mattson, K., Knuutila, S.
Vydáno 1997

Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.

Autor Tiainen, M., Tammilehto, L., Rautonen, J., Tuomi, T., Mattson, K., Knuutila, S.
Vydáno 1989

High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma

Autor Halme, M, Knuuttila, A, Vehmas, T, Tammilehto, L, Mäntylä, M, Salo, J, Mattson, K
Vydáno 1999

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines.

Autor Ungar, S., Van de Meeren, A., Tammilehto, L., Linnainmaa, K., Mattson, K., Gerwin, B. I.
Vydáno 1996

Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.

Autor Björkqvist, A. M., Tammilehto, L., Nordling, S., Nurminen, M., Anttila, S., Mattson, K., Knuutila, S.
Vydáno 1998

Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis

Autor Björkqvist, A-M, Wolf, M, Nordling, S, Tammilehto, L, Knuuttila, A, Kere, J, Mattson, K, Knuutila, S
Vydáno 1999

Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer

Autor Scagliotti, G V, Szczesna, A, Ramlau, R, Cardenal, F, Mattson, K, Van Zandwijk, N, Price, A, Lebeau, B, Debus, J, Manegold, C
Vydáno 2006